Evidence map›Paper›PMID 37365191›Full record

SynthesisScientific reports2023

Neuropsychological deficits in patients with persistent COVID-19 symptoms: a systematic review and meta-analysis.

Saioa Sobrino-Relaño, Yolanda Balboa-Bandeira, Javier Peña, Naroa Ibarretxe-Bilbao, Leire Zubiaurre-Elorza, Natalia Ojeda

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 42 citations in OpenAlex.

  1. Definitions and symptoms of the post-COVID syndrome: an updated systematic umbrella review.European archives of psychiatry and clinical neuroscience · 2025
    Pooled it
  2. Trial
  3. Article
  4. Increased incidence of mild cognitive impairment in long COVID patients.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Observational
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Saioa Sobrino-RelañoDepartment of Psychology, Faculty of Health Sciences, University of Deusto, Av. de Las Universidades, 24, 48007, Bilbao, Spain.
Yolanda Balboa-BandeiraDepartment of Psychology, Faculty of Health Sciences, University of Deusto, Av. de Las Universidades, 24, 48007, Bilbao, Spain.
Javier PeñaDepartment of Psychology, Faculty of Health Sciences, University of Deusto, Av. de Las Universidades, 24, 48007, Bilbao, Spain.ORCID 0000-0002-0041-7020
Naroa Ibarretxe-BilbaoDepartment of Psychology, Faculty of Health Sciences, University of Deusto, Av. de Las Universidades, 24, 48007, Bilbao, Spain.
Leire Zubiaurre-ElorzaDepartment of Psychology, Faculty of Health Sciences, University of Deusto, Av. de Las Universidades, 24, 48007, Bilbao, Spain.
Natalia OjedaDepartment of Psychology, Faculty of Health Sciences, University of Deusto, Av. de Las Universidades, 24, 48007, Bilbao, Spain. nojeda@deusto.es.
Universidad de Deusto · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term persistent symptoms of COVID-19 affect 30-80% of patients who have recovered from the disease and may continue for a long time after the disease has been overcome. The duration of these symptoms over time might have consequences that affect different aspects of health, such as cognitive abilities. The main objective of this systematic review and meta-analysis was to objectify the persistent COVID-19 cognitive deficits after acute phase of infection and to summarize the existing evidence. Additionally, we aimed to provide a comprehensive overview to further understand and address the consequences of this disease. Our protocol was registered in PROSPERO (CRD42021260286). Systematic research was conducted in the Web of Science, MEDLINE, PubMed, PsycINFO, Scopus, and Google Scholar databases from January 2020 to September 2021. Twenty-five studies were included, six of which were analyzed for the meta-analysis, and consisted of 175 patients who had recovered from COVID-19 and 275 healthy individuals. Analyses of cognitive performance of post-COVID-19 patients and healthy volunteers were compared using a random-effects model. The results showed an overall medium-high effect size (g = -.68, p = .02) with a 95% CI (-1.05 to -.31), with a significantly moderate level of heterogeneity among studies (Z = 3.58, p < .001; I

Indexed as

Cognition DisordersCognitive DysfunctionCOVID-19CognitionHumans

Identifiers

PMID37365191
PMCPMC10293265
OpenAlexW4382134906

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.